vimarsana.com
Home
Live Updates
NeuroPace Announces Early Completion of Patient Enrollment i
NeuroPace Announces Early Completion of Patient Enrollment i
NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study
NAUTILUS is the first and only pivotal clinical study to evaluate neuromodulation therapy for treating drug refractory idiopathic generalized epilepsy Neuromodulation therapy is not currently...
Related Keywords
United States ,
Martha Morrell ,
Jeremy Feffer ,
Epilepsy Center ,
Globenewswire Inc ,
Nasdaq ,
Exchange Commission ,
Neuropace Inc ,
Drug Administration ,
Chief Medical ,
Comprehensive Epilepsy Center ,
Investigational Device Exemption ,
Device Designation ,
Financial Condition ,
Annual Report ,
Quarterly Report ,
Markets ,